Ryukou K, Date Y, Iwanari O, Miyako J, Yoshino N, Aoki S, Kitao M, Yoshikawa K, Fujita Y, Yasui K
Dept. of Obstetrics and Gynecology, Shimane Medical University.
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2797-800.
Selective intra arterial hypertensive infusion of CDDP (100 mg) and PEP (40 mg) with angiotensin II was performed in a 64 year-old housewife with inoperable uterine cervical cancer stage IVa and transitional cell cancer of bladder (grade 1-2). PEP at 5 mg/day was also administered for 20 days (total 100 mg) using an implanted Drug Delivery System through the left internal iliac artery combined with irradiation therapy. There were hardly any side effects due to this treatment except for a slight upper digestive tract disturbance and bone marrow suppression, and the cancerous lesion gradually regressed following this treatment. This case suggested the efficacy of intra-arterial infusion using an implanted Drug Delivery System for advanced uterine cervical cancer. There has been no sign of recurrence six months after this treatment.
对一名64岁患有无法手术的IVa期子宫颈癌和膀胱移行细胞癌(1-2级)的家庭主妇,进行了顺铂(100毫克)和培美曲塞(40毫克)与血管紧张素II的选择性动脉内高血压灌注。还通过左髂内动脉使用植入式给药系统给予培美曲塞,剂量为5毫克/天,共20天(总计100毫克),同时结合放射治疗。除了轻微的上消化道不适和骨髓抑制外,该治疗几乎没有任何副作用,治疗后癌性病变逐渐消退。该病例提示了使用植入式给药系统进行动脉内灌注治疗晚期子宫颈癌的有效性。治疗后六个月没有复发迹象。